Bullfrog AI Holdings, Inc. Common Stock (BFRG) Stock Analysis & Investment Frameworks

Bullfrog AI Holdings, Inc. Common Stock (BFRG) stock analysis on Invetso. Review Bullfrog AI Holdings, Inc. Common Stock’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Bullfrog AI Holdings, Inc. Common Stock Company Overview

Bullfrog AI Holdings, Inc. Common Stock Key Financial Metrics

About Bullfrog AI Holdings, Inc. Common Stock

BullFrog AI Holdings, Inc., along with its affiliated entities, functions as an advanced digital biopharmaceutical firm. Its core mission involves harnessing artificial intelligence and machine learning (AI/ML) to process and interpret extensive medical and healthcare datasets specifically within the United States. A central offering is bfLEAP, a proprietary AI/ML platform meticulously crafted for the thorough examination of both preclinical and clinical research data. The company has also secured critical intellectual property through licensing agreements. One such accord, with George Washington University, provides rights to utilize siRNA targeting Beta2-spectrin. This technology is being investigated for its therapeutic potential across a spectrum of human conditions, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, a partnership with Johns Hopkins University grants access to a distinct Mebendazole formulation, developed for the treatment of various human cancers or neoplastic diseases. Founded in 2017, BullFrog AI Holdings, Inc. operates from its headquarters in Gaithersburg, Maryland.

Bullfrog AI Holdings, Inc. Common Stock Investment Frameworks

Invetso analyzes Bullfrog AI Holdings, Inc. Common Stock (BFRG) across the following frameworks:

Explore More BFRG Research